marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Amphastar Pharmaceuticals General and Administrative Expenses 2011-2024 | AMPH
Annual General and Administrative Expenses Amphastar Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.5 M | 45.1 M | 51.4 M | 50.4 M | 50.3 M | 49.9 M | 44.5 M | 41.8 M | 41.5 M | 34.8 M | 31 M | 27.2 M | 26.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 51.5 M | 26.4 M | 42 M |
Quarterly General and Administrative Expenses Amphastar Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.8 M | 13.3 M | - | 12.7 M | 12.3 M | 13.5 M | - | 12 M | 9.98 M | 12.5 M | - | 10.9 M | 14.6 M | 15.3 M | - | 11.7 M | 15.9 M | 10.7 M | - | 11 M | 12.4 M | 16.3 M | - | 13.4 M | 11.7 M | 11 M | - | 11.7 M | 12.2 M | 11.3 M | - | 10.8 M | 9.46 M | 10.9 M | - | 9.03 M | 11.3 M | 12.5 M | - | 9.56 M | 8.64 M | 6.84 M | - | 9.54 M | 6.51 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.3 M | 6.51 M | 11.7 M |